GOLIMUMAB INHIBITS PROGRESSION OF RADIOGRAPHIC DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS: 52 WEEK RESULTS FROM THE GO-REVEAL STUDY

被引：0
|
作者：
Kavanaugh, A. [1 ]
van der Heijde, D. [2 ]
Chattopadhyay, Chandra
Gladman, D. [3 ]
Mease, P. [4 ]
McInnes, I. [5 ]
Krueger, G. G. [6 ]
Xu, W. [7 ]
Rahman, M. U. [8 ,9 ]
Zrubek, J. [8 ]
Baratelle, A. [8 ]
Beutler, A.
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
[4] Univ Washington, Swedish Med Ctr, Seattle, WA 98195 USA
[5] Univ Glasgow, Glasgow, Lanark, Scotland
[6] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA
[7] Centocor Res & Dev Inc, Biostat, Malvern, PA USA
[8] Centocor Res & Dev Inc, Immunol, Malvern, PA USA
[9] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
来源：
RHEUMATOLOGY | 2011年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：143 / 143
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52 Week Results from a Phase 3 Study
    Mease, Philip J.
    Okada, Masato
    Kishimoto, Mitsumasa
    Shuler, Catherine L.
    Carlier, Hilde
    Lin, Chen-Yen
    Mou, Jiani
    Moriarty, Susan R.
    Lee, Chin H.
    Gladman, Dafna D.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [42] Radiographic Progression Inhibition with Intravenous Golimumab in Psoriatic Arthritis: Week 24 Results of a Phase III, Randomized, Double-blind, Placebo-controlled Trial
    Kavanaugh, Arthur
    Husni, M. Elaine
    Harrison, Diane D.
    Kim, Lilianne
    Lo, Kim Hung
    Noonan, Lenore
    Hsia, Elizabeth C.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (06) : 595 - 602
  • [43] Golimumab reduces disease activity of rheumatoid arthritis for 1 year and strongly inhibits radiographic progression in Japanese patients: partial but detailed results of the GO-FORTH and GO-MONO studies
    Hayashi, Masatoshi
    Kobayakawa, Tomonori
    Takanashi, Tetsuo
    Yamazaki, Hideshi
    Ishikawa, Hisato
    Kanamono, Toshihisa
    CLINICAL RHEUMATOLOGY, 2013, 32 (07) : 961 - 967
  • [44] CLINICAL MEANINGFULNESS OF RADIOGRAPHIC JOINT DAMAGE ON PHYSICAL FUNCTION, EMPLOYABILITY AND WORK PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE INTRAVENOUS GOLIMUMAB STUDY, GO-FURTHER
    Han, C.
    Bingham, C. O.
    Westhovens, R.
    Weinblatt, M. E.
    Kim, L.
    Baker, D.
    Peterson, S.
    Hsia, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1031 - 1031
  • [45] Golimumab reduces disease activity of rheumatoid arthritis for 1 year and strongly inhibits radiographic progression in Japanese patients: partial but detailed results of the GO-FORTH and GO-MONO studies
    Masatoshi Hayashi
    Tomonori Kobayakawa
    Tetsuo Takanashi
    Hideshi Yamazaki
    Hisato Ishikawa
    Toshihisa Kanamono
    Clinical Rheumatology, 2013, 32 : 961 - 967
  • [46] Secukinumab inhibits radiographic progression in patients with psoriatic arthritis: Results of phase 3 FUTURE 1 study stratified by concomitant methotrexate use
    Gottlieb, Alice
    Mease, Philip
    McInnes, Iain
    Mpofu, Shephard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB271 - AB271
  • [47] The Association Between Obesity and Radiographic Progression Of Joint Damage Among Patients With Psoriatic Arthritis
    Eder, Lihi
    Thavaneswaran, Arane
    Chandran, Vinod
    Cook, Richard J.
    Gladman, Dafna D.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S146 - S147
  • [48] Adalimumab treatment effects on radiographic progression of joint disease in patients with psoriatic arthritis: Results from ADEPT
    Mease, PJ
    Sharp, JT
    Ory, P
    Gladman, DD
    Ritchlin, CT
    Choy, EH
    Weinberg, MA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 320 - 320
  • [49] Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients With Psoriatic Arthritis: 24-Week Results of the GO-VIBRANT Trial
    Husni, M. Elaine
    Kavanaugh, Arthur
    Chan, Eric K. H.
    Peterson, Steven
    Li, Nan
    Hsia, Elizabeth C.
    Kim, Lilianne
    Lo, Kim Hung
    Harrison, Diane D.
    Han, Chenglong
    VALUE IN HEALTH, 2020, 23 (10) : 1286 - 1291
  • [50] Golimumab, A New, Human, TNF Alpha Antibody, Administered SC Every 4 Weeks in PsA Patients: 104-Week Efficacy and Safety Results of the Randomized, Placebo-Controlled GO-REVEAL Study
    Gladman, Dafna
    Kavanaugh, Arthur
    Mease, Philip
    Krueger, Gerald
    Zrubek, Julie
    Beutler, Anna
    Hsu, Benjamin
    Mudivarthy, Surekha
    Mack, Michael
    McInnes, Iain
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1327 - 1327
12345